课题基金 / 基金详情

HHV 8 AND KAPOSIS SARCOMA

HHV 8 AND KAPOSIS SARCOMA
HHV 8 和卡波西斯肉瘤
批准号:
6172707
负责人:
BRIAN J NICKOLOFF
金额:
$27.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-16 至 2002-03-31

项目摘要

项目成果

BRIAN J NICKOLOFF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Applicant's Abstract) Kaposi's sarcoma (KS) is a multifocal neoplasm that frequently complicates the clinical course of HIV-I positive individuals. As AIDS patients are living longer due to better treatment with reduction of their HIV-1 viral load, secondary tumor such as KS and non-Hodgkins lymphomas are becoming more common and problematic for clinicians. A significant problem in combating KS has been lack of identification of a clear-cut etiological agent, as well as absence of an animal model that contains all of the relevant human cellular constituents of KS lesions. Indeed, KS is a complex neoplasm that features participation of several different cell types including proliferating spindle-shaped tumor cells, endothelial cells, and dermal dendritic cells. Recently a novel DNA virus has been suggested as a plausible etiological agent (i.e. human herpesvirus-8; HHV-8), and a SCID-human skin grafting procedure developed. In this proposal, these advances are combined to determine if HHV-8 can cause cutaneous KS lesions in this novel animal model system. Once HHV-8 is introduced into engrafted full-thickness human skin, specific cell types that become infected and support viral DNA and RNA production will be identified using highly sensitive and specific localization techniques. In addition, the role of cytokines in HHV-8 induced KS will be examined with specific emphasis on induction of angiogenesis and expansile tumor formation. The range of potential mesenchymal cell targets in-vivo and in-vitro for HHV-8 will be determined, the influence of immunomodulatory agents on the multi-step process of KS lesion formation will be examined. To address the void in effective treatment modalities for KS, particularly in the setting of AIDS, this animal model system will be used to test the efficacy of anti-herpes agents at either preventing or reversing KS lesions. By successfully completing all 4 aims over the next 4 years, a better understanding of the etiology and pathophysiology of this common, enigmatic, and potentially deadly neoplasm will be had
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Premature Keratinocyte Apoptosis in GVHD
Core--Skin Analysis and Epidermal Engineering
Cell Death in Normal and Diseased Human Epidermis
  • 批准号:
    6749517
  • 项目类别:
  • 资助金额:
    $32.3万
  • 财政年份:
    2002
  • 负责人:
    BRIAN J NICKOLOFF
  • 依托单位:
Cell Death in Normal and Diseased Human Epidermis
  • 批准号:
    6469909
  • 项目类别:
  • 资助金额:
    $32.3万
  • 财政年份:
    2002
  • 负责人:
    BRIAN J NICKOLOFF
  • 依托单位:
海外基金